InvestorsHub Logo
Followers 130
Posts 14996
Boards Moderated 1
Alias Born 06/04/2018

Re: None

Thursday, 09/03/2020 3:00:11 PM

Thursday, September 03, 2020 3:00:11 PM

Post# of 675
BREAKING NEWS: $EARS Auris Medical Announces Positive Interim Data from TRAVERS Phase 2 Study with AM-125 in Vertigo

Dose dependent improvement in balance tests over placebo in Part A of TRAVERS trial Improvement 1.9 to 2.4 times greater with highest dose than with placebo Trial to proceed with Part B to test AM-125 10 and 20 mg vs. placebo   Hamilton, Bermuda, September 3, 2020 – Auris ...

In case you are interested EARS - Auris Medical Announces Positive Interim Data from TRAVERS Phase 2 Study with AM-125 in Vertigo